Efficacy and Safety of Tildrakizumab in Older Patients: Pooled Analyses of Two Randomized Phase III Clinical Trials (reSURFACE 1 and reSURFACE 2) Through 244 Weeks
Loading...
Date
Authors
Haar, E.L.M. Elke
Reek, J.M.P.A. Juul
Jardin, Kristian Gaarn Du
Barbero-castillo, Almudena
Jong, E.M.G.J. Elke
Lubeek, S.F.K. Satish